Cargando...

Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer

BACKGROUND: Cetuximab and panitumumab are monoclonal antibodies targeting the epidermal growth factor receptor. Both drugs are active against RAS wild type metastatic colorectal cancer after chemotherapy failure, with similar efficacy and toxicity profiles. However, their cost and limited survival b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Carvalho, Adriana Camargo, Leal, Frederico, Sasse, Andre Deeke
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389795/
https://ncbi.nlm.nih.gov/pubmed/28403233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175409
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!